| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M7711 | Cloricromene | Antithrombotic coumarin derivative that inhibits platelet and leukocyte function and suppresses arachidonic acid liberation by interfering with PLA2 activation. |
| M7710 | 9-Cyclopentyladenine monomethanesulfonate | A stable, cell-permeable, non-competitive adenylyl cyclase inhibitor that targets the P-site domain. |
| M7708 | CPNQ | Misfolded proteins accumulate in many neurodegenerative diseases, including huntingtin in Huntington′s disease and alpha-synuclein in Parkinson′s disease. |
| M7705 | Cyclazosin hydrochloride | α1B-adrenoceptor antagonist. |
| M7703 | Clofilium tosylate | K+ channel blocker; cardiac depressant; anti-arrhythmic. |
| M7697 | Chlorprothixene hydrochloride | D2 dopamine receptor antagonist; blocks a subset of GABAA receptors in rat cortex that is also blocked by clozapine; thioxanthine antipsychotic. |
| M7695 | CGS-9343B | CGS-9343B is a selective calmodulin antagonist with minimal protein kinase C or antidopaminergic activity. |
| M7694 | Cibenzoline succinate | Dibenzazoline is a class IA antiarrhythmic compound. |
| M7689 | Caroverine hydrochloride | Caroverine hydrochloride is a nonselective NMDA and AMPA glutamate receptor antagonist. |
| M7688 | Chrysamine G | New probe for ß-amyloid aggregates. |
| M7687 | CGS-12066 maleate salt | 5-HT1B serotonin receptor agonist. |
| M7686 | cDPCP | cDPCP is a tumor cell permeable, potent platinum-based antineoplastic agent. |
| M7682 | III-31-C | III-31-C is a (hydroxyethyl)urea γ-secretase inhibitor that binds to γ-secretase at the substrate docking site. |
| M7679 | Acetylethylcholine mustard hydrochloride | Acetylethylcholine mustard is a precursor for ethylcholine mustard aziridinium ion (AF-64A); irreversible ligand for the high affinity choline transport system; specific presynaptic long action cholinotoxin; inhibitor of choline acetyl-transferase. |
| M7678 | BMS-764459 | BMS-764459 is a pyrazinone-containing antagonist that targets corticotropin-releasing factor/hormone (CRF or CRH) receptor 1 (CRF1, CRF-R1, CRFR-1, CRH-R1, CRHR-1) with high affinity (IC50 = 0. |
| M7677 | BMS-665053 | BMS-665053 is a pyrazinone-containing antagonist that targets corticotropin-releasing factor/hormone (CRF or CRH) receptor 1 (CRF1, CRF-R1, CRFR-1, CRH-R1, CRHR-1) with high affinity (IC50 |
| M7676 | BMS-763534 | BMS-763534 is a pyrazinone-containing antagonist that targets corticotropin-releasing factor/hormone (CRF or CRH) receptor 1 (CRF1, CRF-R1, CRFR-1, CRH-R1, CRHR-1) with high affinity (IC50 = 0. |
| M7675 | BMS-248360 | BMS-248360 is an orally active dual antagonist of angiotensin II subtype 1 (AT1) and endothelin subtype A (ETA) receptors. |
| M7673 | BMS-870145 | BMS-870145 is an orally available, potent and selective P2Y1 purinergic receptor antagonist. |
| M7672 | BMS-986034 | BMS-986034 is a GPR119 agonist. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
